Lab Product News
News

$6M funding supports studies into long-term effects of women’s cancer drugs


Toronto, ON – Dr Tom Hudson, president and scientific director of the Ontario Institute for Cancer Research (OICR), and Dr Terrence Sullivan, president and CEO of Cancer Care Ontario (CCO), announce $6 million in funding for projects in the Health Services Research Program (HSRP).

“This funding will provide Ontario’s researchers with the support they need to ensure that the delivery of cancer care in the province is continually improving,” said Dr Hudson. “Additionally, we hope to provide a benchmark for other jurisdictions, specifically in important areas such as women’s cancer survivorship.”

Under the Program, the Women’s Cancer Survivorship Team – studying the late and long-term effects of cancer drug therapy – will receive over $800,000 in funding.

Using an interdisciplinary approach, the Women’s Cancer Survivorship Team, led by Drs Geoff Anderson and Paula Rochon of Women’s College Hospital, will study the complex interplay between cancer and other medical conditions in survivors of early stage breast cancer that have been treated with the latest generation of cancer drugs.

“This funding will be applied to important health services research focused on the cancer system,” said Dr Sullivan.” Through the translation of these research findings, we will uncover practical ways of organizing cancer services. This will result in better overall outcomes for cancer patients.”

The projects funded include:

• CCO/OICR Health Services Research Network;
• Women’s cancer survivorship team: Late effects of cancer drug therapy;
• Investigating the impact of the Colon Cancer Check: Primary care invitation pilot;
• Knowledge Translation Research Network;
• Evaluation of a health care policy intervention to change the organization and delivery of lung cancer surgery in Ontario;
• Patient and provider reported outcomes in cancer patients in Ontario;
• Case costing of cancer in Ontario;
• The Ontario Cancer Data Linkage Project.

“This unprecedented investment in cancer health services research is contributing to a future in which fewer people develop cancer, those who do are diagnosed promptly and at earlier stages, treatment is safer, more equitable, and of higher quality, and the cancer system is economically sustainable,” said Dr Craig Earle, program leader, Health Services Research.